001     296022
005     20250203161129.0
024 7 _ |a 10.1158/1078-0432.CCR-24-0581
|2 doi
024 7 _ |a pmid:39625867
|2 pmid
024 7 _ |a 1078-0432
|2 ISSN
024 7 _ |a 1557-3265
|2 ISSN
024 7 _ |a altmetric:171529367
|2 altmetric
037 _ _ |a DKFZ-2024-02765
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lamoureux, Audrey-Anne
|0 0009-0008-3878-8995
|b 0
245 _ _ |a Clinical characteristics and outcome of central nervous system tumors harboring NTRK gene fusions.
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2025
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738595438_22142
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Feb 3;31(3):561-572
520 _ _ |a TRK fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients.We conducted an international retrospective cohort study of patients with TRK fusion-driven CNS tumors.119 patients were identified. The median age at time of diagnosis was 4.5 years. The majority were reported to have a histology consistent with a diagnosis of high-grade glioma (HGG) (57.1%) followed by low-grade glioma (LGG) (27.7%). Pediatric patients had a better prognosis with a median overall survival of 185.5 months compared to 24.8 months in adults (p<.0001). Patients with LGG also had a better outcome when compared to HGG (p=0.0012). The objective response was 68.8% with larotrectinib compared to 38.1% for non-targeted treatment.Children with LGG glioma had a favorable outcome compared to adult and HGG. TRK inhibitors appear to improve tumor control.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Fisher, Michael J
|0 0000-0003-3408-3839
|b 1
700 1 _ |a Lemelle, Lauriane
|0 0000-0002-3333-5048
|b 2
700 1 _ |a Pfaff, Elke
|0 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
|b 3
|u dkfz
700 1 _ |a Amir-Yazdani, Pouneh
|0 0000-0001-8403-7131
|b 4
700 1 _ |a Kramm, Christof
|0 0000-0002-5017-926X
|b 5
700 1 _ |a De Wilde, Bram
|0 0000-0003-0213-1322
|b 6
700 1 _ |a Kazanowska, Bernarda
|b 7
700 1 _ |a Hutter, Caroline
|0 0000-0003-2059-4814
|b 8
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 9
|u dkfz
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 10
|u dkfz
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 11
|u dkfz
700 1 _ |a Orbach, Daniel
|0 0000-0002-2520-139X
|b 12
700 1 _ |a Pierron, Gaëlle
|0 0000-0002-2536-7680
|b 13
700 1 _ |a Raskin, Scott
|0 0000-0003-1160-9842
|b 14
700 1 _ |a Drilon, Alexander
|0 0000-0001-6806-9061
|b 15
700 1 _ |a Diamond, Eli L
|0 0000-0001-5456-5961
|b 16
700 1 _ |a Harada, Guilherme
|0 0000-0003-4012-3251
|b 17
700 1 _ |a Zapotocky, Michal
|0 0000-0002-9013-2546
|b 18
700 1 _ |a Zamecnik, Josef
|0 0000-0001-8697-9632
|b 19
700 1 _ |a Krskova, Lenka
|0 0000-0002-6113-6310
|b 20
700 1 _ |a Ellezam, Benjamin
|0 0000-0002-8716-7924
|b 21
700 1 _ |a Weil, Alexander G
|0 0000-0003-4162-6096
|b 22
700 1 _ |a Venne, Dominic
|0 0000-0003-3978-3738
|b 23
700 1 _ |a Barritault, Marc
|0 0000-0003-3311-4058
|b 24
700 1 _ |a Leblond, Pierre
|0 0000-0002-7088-2614
|b 25
700 1 _ |a Coltin, Hallie
|0 0000-0003-0820-6276
|b 26
700 1 _ |a Hammad, Rawan
|0 0000-0001-6293-7497
|b 27
700 1 _ |a Tabori, Uri
|0 0000-0002-5019-2683
|b 28
700 1 _ |a Hawkins, Cynthia
|0 0000-0003-2618-4402
|b 29
700 1 _ |a Hansford, Jordan R
|0 0000-0001-7733-383X
|b 30
700 1 _ |a Meyran, Deborah
|0 0000-0003-2723-8185
|b 31
700 1 _ |a Erker, Craig
|0 0000-0003-1394-7167
|b 32
700 1 _ |a McFadden, Kathryn
|0 0000-0002-7007-2267
|b 33
700 1 _ |a Sato, Mariko
|0 0000-0002-4748-4634
|b 34
700 1 _ |a Gottardo, Nicholas G
|0 0000-0002-1082-6776
|b 35
700 1 _ |a Dholaria, Hetal
|0 0000-0003-1713-3822
|b 36
700 1 _ |a Nørøxe, Dorte Schou
|0 0000-0001-9921-8277
|b 37
700 1 _ |a Goto, Hiroaki
|0 0000-0001-6737-1509
|b 38
700 1 _ |a Ziegler, David S
|0 0000-0001-7451-7916
|b 39
700 1 _ |a Lin, Frank Y
|0 0000-0001-6738-844X
|b 40
700 1 _ |a Parsons, Donald Williams
|0 0000-0002-8775-3501
|b 41
700 1 _ |a Lindsay, Holly
|0 0000-0001-5654-841X
|b 42
700 1 _ |a Wong, Tai-Tong
|0 0000-0003-4075-6227
|b 43
700 1 _ |a Liu, Yen-Lin
|0 0000-0002-7571-3123
|b 44
700 1 _ |a Wu, Kuo-Sheng
|0 0009-0001-1887-9768
|b 45
700 1 _ |a Franson, Andrea T
|0 0000-0002-5361-7683
|b 46
700 1 _ |a Hwang, Eugene
|0 0000-0002-3923-1135
|b 47
700 1 _ |a Aguilar-Bonilla, Ana
|0 0000-0002-5327-449X
|b 48
700 1 _ |a Cheng, Sylvia
|0 0000-0002-4089-1739
|b 49
700 1 _ |a Cacciotti, Chantel
|0 0000-0002-4968-8956
|b 50
700 1 _ |a Massimino, Maura
|0 0000-0002-5506-2001
|b 51
700 1 _ |a Schiavello, Elisabetta
|0 0000-0002-8049-7445
|b 52
700 1 _ |a Wood, Paul
|0 0000-0003-1383-3450
|b 53
700 1 _ |a Hoffman, Lindsey M
|0 0000-0002-8573-1747
|b 54
700 1 _ |a Cappellano, Andréa
|0 0000-0002-3818-8876
|b 55
700 1 _ |a Lassaletta, Alvaro
|0 0000-0003-2881-1473
|b 56
700 1 _ |a Van Damme, An
|0 0000-0002-7114-201X
|b 57
700 1 _ |a Llort, Anna
|0 0000-0001-9741-1655
|b 58
700 1 _ |a Gerber, Nicolas U
|0 0000-0002-1783-631X
|b 59
700 1 _ |a Spalato Ceruso, Mariella
|0 0000-0002-7582-3365
|b 60
700 1 _ |a Bendel, Anne E
|0 0000-0002-2062-0974
|b 61
700 1 _ |a Skrypek, Maggie
|0 0009-0009-0158-9594
|b 62
700 1 _ |a Hamideh, Dima
|0 0000-0003-2246-6621
|b 63
700 1 _ |a Mushtaq, Naureen
|0 0000-0002-5461-3350
|b 64
700 1 _ |a Walter, Andrew
|0 0000-0001-5653-5686
|b 65
700 1 _ |a Jabado, Nada
|0 0000-0003-2485-3692
|b 66
700 1 _ |a Alsahlawi, Aysha
|0 0009-0003-5157-5226
|b 67
700 1 _ |a Farmer, Jean-Pierre
|0 0000-0003-2242-1984
|b 68
700 1 _ |a Coleman, Christina
|0 0000-0001-5747-4045
|b 69
700 1 _ |a Mueller, Sabine
|0 0000-0002-3452-5150
|b 70
700 1 _ |a Mazewski, Claire
|0 0000-0001-6970-0994
|b 71
700 1 _ |a Aguilera, Dolly
|0 0000-0001-9668-8177
|b 72
700 1 _ |a Robison, Nathan J
|0 0000-0001-8613-9772
|b 73
700 1 _ |a O'Halloran, Katrina
|0 0000-0003-0573-0769
|b 74
700 1 _ |a Abbou, Samuel
|0 0000-0002-7159-8869
|b 75
700 1 _ |a Berlanga, Pablo
|0 0000-0003-1110-7789
|b 76
700 1 _ |a Geoerger, Birgit
|0 0000-0003-4361-3643
|b 77
700 1 _ |a Øra, Ingrid
|0 0000-0002-3931-4125
|b 78
700 1 _ |a Moertel, Christopher L
|0 0000-0002-5474-588X
|b 79
700 1 _ |a Razis, Evangelia D
|0 0000-0003-3873-2947
|b 80
700 1 _ |a Vernadou, Anastasia
|0 0009-0005-1733-0625
|b 81
700 1 _ |a Ducray, François
|0 0000-0002-8150-5785
|b 82
700 1 _ |a Bronnimann, Charlotte
|0 0000-0002-2208-0545
|b 83
700 1 _ |a Seizeur, Romuald
|0 0000-0001-6519-9098
|b 84
700 1 _ |a Clarke, Matthew
|0 0000-0003-2405-5770
|b 85
700 1 _ |a Resnick, Adam C
|0 0000-0003-0436-4189
|b 86
700 1 _ |a Alves, Mélanie
|0 0009-0001-7243-3134
|b 87
700 1 _ |a Jones, Chris
|0 0000-0001-8118-2296
|b 88
700 1 _ |a Doz, François
|0 0000-0001-9286-4831
|b 89
700 1 _ |a Laetsch, Theodore W
|0 0000-0002-8497-3138
|b 90
700 1 _ |a Perreault, Sébastien
|0 0000-0002-4417-7698
|b 91
773 _ _ |a 10.1158/1078-0432.CCR-24-0581
|0 PERI:(DE-600)2036787-9
|n 3
|p 561-572
|t Clinical cancer research
|v 31
|y 2025
|x 1078-0432
909 C O |p VDB
|o oai:inrepo02.dkfz.de:296022
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)551bb92841f634070997aa168d818492
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)B360-20160331
|k B360
|l Pädiatrische Gliomforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B360-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21